Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 14.91 is 60% below its 5-year average of 37.39, near the low end of its 5-year range (13.80–84.09).
As of the fiscal period ended Tuesday, June 30, 2026. 16.94% below its 12-month average of 17.94.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 14.91.
QUICK RATIO (ACID-TEST)
14.91
QUICK RATIO (ACID-TEST) AVG TTM
17.94
QUICK RATIO (ACID-TEST) AVG 3Y
25.20
QUICK RATIO (ACID-TEST) AVG 5Y
37.39
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-16.94%
CURRENT VS 3Y AVG
-40.86%
CURRENT VS 5Y AVG
-60.14%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+344.93%
vs the sector median at left
Tyra Biosciences, Inc.
Market Cap
$1.21B
Quick Ratio (Acid-Test)
14.91
TTM Avg
17.94
3Y Avg
25.20
5Y Avg
37.39
Market Cap
$1.20B
Quick Ratio (Acid-Test)
19.73
TTM Avg
13.53
3Y Avg
9.78
5Y Avg
15.63
Market Cap
$1.22B
Quick Ratio (Acid-Test)
1.05
TTM Avg
1.06
3Y Avg
1.16
5Y Avg
1.68
Market Cap
$1.23B
Quick Ratio (Acid-Test)
15.25
TTM Avg
18.40
3Y Avg
18.04
5Y Avg
16.30
Market Cap
$1.18B
Quick Ratio (Acid-Test)
1.41
TTM Avg
2.22
3Y Avg
2.73
5Y Avg
2.72
Market Cap
$1.24B
Quick Ratio (Acid-Test)
13.19
TTM Avg
12.35
3Y Avg
12.19
5Y Avg
16.27
Market Cap
$1.14B
Quick Ratio (Acid-Test)
10.42
TTM Avg
4.62
3Y Avg
5.77
5Y Avg
6.99
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tyra Biosciences, Inc. (TYRA) | $1.21B | 14.91 | 17.94 | 25.20 | 37.39 |
| Kardigan, Inc. (KARD)vs › | $1.21B | 8.72 | 9.20 | 9.20 | 9.20 |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.20B | 19.73 | 13.53 | 9.78 | 15.63 |
| Innovage Holding Corp. (INNV)vs › | $1.22B | 1.05 | 1.06 | 1.16 | 1.68 |
| Cronos Group Inc. (CRON)vs › | $1.23B | 15.25 | 18.40 | 18.04 | 16.30 |
| MannKind Corporation (MNKD)vs › | $1.18B | 1.41 | 2.22 | 2.73 | 2.72 |
| Omada Health (OMDA)vs › | $1.23B | 3.85 | 2.79 | 3.53 | 3.53 |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.24B | 13.19 | 12.35 | 12.19 | 16.27 |
| Nektar Therapeutics (NKTR)vs › | $1.14B | 10.42 | 4.62 | 5.77 | 6.99 |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.14B | 1.71 | 2.54 | 2.42 | 2.25 |
Quick Ratio
14.91
Excludes inventory
Current Ratio
14.91
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 14.91 |
| 2026-03-31 | 20.49 |
| 2025-12-31 | 14.67 |
| 2025-09-30 | 17.71 |
| 2025-06-30 | 21.94 |
| 2025-03-31 | 22.78 |
| 2024-12-31 | 23.81 |
| 2024-09-30 | 29.55 |
| 2024-06-30 | 36.46 |
| 2024-03-31 | 44.83 |
| 2023-12-31 | 13.80 |
| 2023-09-30 | 22.14 |
| 2023-06-30 | 44.54 |
| 2023-03-31 | 67.00 |
| 2022-12-31 | 45.13 |
| 2022-09-30 | 48.73 |
| 2022-06-30 | 50.83 |
| 2022-03-31 | 59.99 |
| 2021-12-31 | 84.09 |
| 2021-09-30 | 65.75 |
| 2021-06-30 | 36.12 |
| 2021-03-31 | 91.74 |
| 2020-12-31 | 8.22 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
